<DOC>
	<DOCNO>NCT00788749</DOCNO>
	<brief_summary>This first randomized parallel group clinical trial look oral prednisolone induce medical nasal polypectomy follow maintenance topical steroid therapy patient nasal polyposis . This study also look effect aspirin sensitivity factor link nasal polyp asthma . We also take baseline measurement variety blood , surface biopsy marker assess potential predict steroid response . Finally , still unchartered link nasal polyp asthma explore measure Staphylococcal superantigens serum treatment .</brief_summary>
	<brief_title>Medical Polypectomy Predictors Response</brief_title>
	<detailed_description />
	<mesh_term>Nasal Polyps</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>male female 1875 year age bilateral nasal polyposis Grade 2 without asthma without atopy aspirin sensitivity write informed consent unilateral nasal polyposis polypoid lesion suspicious inverted papilloma , malignancy , Wegeners granulomatosis , sarcoidosis know suspected hypersensitivity fluticasone propionate constituent Investigational Medicinal product ( IMP ) . Any clinically significant medical condition abnormality , , opinion investigator , might compromise safety subject might interfere study . significant ( â‰¥50 % ) septal deviation inability comply requirement protocol female pregnant , lactate plan become pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>chronic rhinosinusitis</keyword>
	<keyword>nasal polyp</keyword>
	<keyword>oral steroid</keyword>
	<keyword>intranasal steroid</keyword>
	<keyword>medical polypectomy</keyword>
</DOC>